Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity.

Parasites & vectors

Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, Lamberton PHL.
PMID: 34991702
Parasit Vectors. 2022 Jan 06;15(1):15. doi: 10.1186/s13071-021-05121-6.

BACKGROUND: Annual mass drug administration with praziquantel has reduced schistosomiasis transmission in some highly endemic areas, but areas with persistent high endemicity have been identified across sub-Saharan Africa, including Uganda. In these areas many children are rapidly reinfected post...

Cite
Trienekens SCM, Faust CL, Besigye F, et al. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasit Vectors. 2022;15(1):15doi: 10.1186/s13071-021-05121-6.
Trienekens, S. C. M., Faust, C. L., Besigye, F., Pickering, L., Tukahebwa, E. M., Seeley, J., & Lamberton, P. H. L. (2022). Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasites & vectors, 15(1), 15. https://doi.org/10.1186/s13071-021-05121-6
Trienekens, Suzan C M, et al. "Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity." Parasites & vectors vol. 15,1 (2022): 15. doi: https://doi.org/10.1186/s13071-021-05121-6
Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, Lamberton PHL. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasit Vectors. 2022 Jan 06;15(1):15. doi: 10.1186/s13071-021-05121-6. PMID: 34991702.
Copy Download .nbib Format: NLM
Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity.

Parasites & vectors

Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, Lamberton PHL.
PMID: 34991702
Parasit Vectors. 2022 Jan 06;15(1):15. doi: 10.1186/s13071-021-05121-6.

BACKGROUND: Annual mass drug administration with praziquantel has reduced schistosomiasis transmission in some highly endemic areas, but areas with persistent high endemicity have been identified across sub-Saharan Africa, including Uganda. In these areas many children are rapidly reinfected post...

Cite
Trienekens SCM, Faust CL, Besigye F, et al. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasit Vectors. 2022;15(1):15doi: 10.1186/s13071-021-05121-6.
Trienekens, S. C. M., Faust, C. L., Besigye, F., Pickering, L., Tukahebwa, E. M., Seeley, J., & Lamberton, P. H. L. (2022). Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasites & vectors, 15(1), 15. https://doi.org/10.1186/s13071-021-05121-6
Trienekens, Suzan C M, et al. "Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity." Parasites & vectors vol. 15,1 (2022): 15. doi: https://doi.org/10.1186/s13071-021-05121-6
Trienekens SCM, Faust CL, Besigye F, Pickering L, Tukahebwa EM, Seeley J, Lamberton PHL. Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity. Parasit Vectors. 2022 Jan 06;15(1):15. doi: 10.1186/s13071-021-05121-6. PMID: 34991702; PMCID: PMC8734346.
Copy Download .nbib Format: NLM
Cellular metabolism and diseases.

British journal of pharmacology

Maiuri MC, Maffia P.
PMID: 33932230
Br J Pharmacol. 2021 May;178(10):2031-2033. doi: 10.1111/bph.15355.

LINKED ARTICLES: This article is part of a themed issue on Cellular metabolism and diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.10/issuetoc.

Cite
Maiuri MC, Maffia P. Cellular metabolism and diseases. Br J Pharmacol. 2021;178(10):2031-2033doi: 10.1111/bph.15355.
Maiuri, M. C., & Maffia, P. (2021). Cellular metabolism and diseases. British journal of pharmacology, 178(10), 2031-2033. https://doi.org/10.1111/bph.15355
Maiuri, Maria Chiara, and Maffia, Pasquale. "Cellular metabolism and diseases." British journal of pharmacology vol. 178,10 (2021): 2031-2033. doi: https://doi.org/10.1111/bph.15355
Maiuri MC, Maffia P. Cellular metabolism and diseases. Br J Pharmacol. 2021 May;178(10):2031-2033. doi: 10.1111/bph.15355. PMID: 33932230.
Copy Download .nbib Format: NLM
ABO Blood Groups Do Not Predict .

Microorganisms

Francoeur R, Atuhaire A, Arinaitwe M, Adriko M, Ajambo D, Nankasi A, Babayan SA, Lamberton PHL.
PMID: 34946048
Microorganisms. 2021 Nov 27;9(12). doi: 10.3390/microorganisms9122448.

No abstract available.

Cite
Francoeur R, Atuhaire A, Arinaitwe M, et al. ABO Blood Groups Do Not Predict . Microorganisms. 2021;9(12)doi: 10.3390/microorganisms9122448.
Francoeur, R., Atuhaire, A., Arinaitwe, M., Adriko, M., Ajambo, D., Nankasi, A., Babayan, S. A., & Lamberton, P. H. L. (2021). ABO Blood Groups Do Not Predict . Microorganisms, 9(12), . https://doi.org/10.3390/microorganisms9122448
Francoeur, Rachel, et al. "ABO Blood Groups Do Not Predict ." Microorganisms vol. 9,12 (2021). doi: https://doi.org/10.3390/microorganisms9122448
Francoeur R, Atuhaire A, Arinaitwe M, Adriko M, Ajambo D, Nankasi A, Babayan SA, Lamberton PHL. ABO Blood Groups Do Not Predict . Microorganisms. 2021 Nov 27;9(12). doi: 10.3390/microorganisms9122448. PMID: 34946048; PMCID: PMC8705964.
Copy Download .nbib Format: NLM
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension.

Cardiovascular research

Rossitto G, Maiolino G, Lerco S, Ceolotto G, Blackburn G, Mary S, Antonelli G, Berton C, Bisogni V, Cesari M, Seccia TM, Lenzini L, Pinato A, Montezano A, Touyz RM, Petrie MC, Daly R, Welsh P, Plebani M, Rossi GP, Delles C.
PMID: 33053160
Cardiovasc Res. 2021 Apr 23;117(5):1372-1381. doi: 10.1093/cvr/cvaa205.

AIMS: A blood pressure (BP)-independent metabolic shift towards a catabolic state upon high sodium (Na+) diet, ultimately favouring body fluid preservation, has recently been described in pre-clinical controlled settings. We sought to investigate the real-life impact of high Na+...

Cite
Rossitto G, Maiolino G, Lerco S, et al. High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. Cardiovasc Res. 2021;117(5):1372-1381doi: 10.1093/cvr/cvaa205.
Rossitto, G., Maiolino, G., Lerco, S., Ceolotto, G., Blackburn, G., Mary, S., Antonelli, G., Berton, C., Bisogni, V., Cesari, M., Seccia, T. M., Lenzini, L., Pinato, A., Montezano, A., Touyz, R. M., Petrie, M. C., Daly, R., Welsh, P., Plebani, M., Rossi, G. P., & Delles, C. (2021). High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. Cardiovascular research, 117(5), 1372-1381. https://doi.org/10.1093/cvr/cvaa205
Rossitto, Giacomo, et al. "High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension." Cardiovascular research vol. 117,5 (2021): 1372-1381. doi: https://doi.org/10.1093/cvr/cvaa205
Rossitto G, Maiolino G, Lerco S, Ceolotto G, Blackburn G, Mary S, Antonelli G, Berton C, Bisogni V, Cesari M, Seccia TM, Lenzini L, Pinato A, Montezano A, Touyz RM, Petrie MC, Daly R, Welsh P, Plebani M, Rossi GP, Delles C. High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. Cardiovasc Res. 2021 Apr 23;117(5):1372-1381. doi: 10.1093/cvr/cvaa205. PMID: 33053160; PMCID: PMC8064429.
Copy Download .nbib Format: NLM
ABO Blood Groups Do Not Predict .

Microorganisms

Francoeur R, Atuhaire A, Arinaitwe M, Adriko M, Ajambo D, Nankasi A, Babayan SA, Lamberton PHL.
PMID: 34946048
Microorganisms. 2021 Nov 27;9(12). doi: 10.3390/microorganisms9122448.

No abstract available.

Cite
Francoeur R, Atuhaire A, Arinaitwe M, et al. ABO Blood Groups Do Not Predict . Microorganisms. 2021;9(12)doi: 10.3390/microorganisms9122448.
Francoeur, R., Atuhaire, A., Arinaitwe, M., Adriko, M., Ajambo, D., Nankasi, A., Babayan, S. A., & Lamberton, P. H. L. (2021). ABO Blood Groups Do Not Predict . Microorganisms, 9(12), . https://doi.org/10.3390/microorganisms9122448
Francoeur, Rachel, et al. "ABO Blood Groups Do Not Predict ." Microorganisms vol. 9,12 (2021). doi: https://doi.org/10.3390/microorganisms9122448
Francoeur R, Atuhaire A, Arinaitwe M, Adriko M, Ajambo D, Nankasi A, Babayan SA, Lamberton PHL. ABO Blood Groups Do Not Predict . Microorganisms. 2021 Nov 27;9(12). doi: 10.3390/microorganisms9122448. PMID: 34946048.
Copy Download .nbib Format: NLM
Molecular imaging-The first visual themed issue published in the British Journal of Pharmacology.

British journal of pharmacology

Maffia P, Antoniades C, Ahluwalia A, Cirino G.
PMID: 34664273
Br J Pharmacol. 2021 Nov;178(21):4213-4215. doi: 10.1111/bph.15632.

No abstract available.

Cite
Maffia P, Antoniades C, Ahluwalia A, et al. Molecular imaging-The first visual themed issue published in the British Journal of Pharmacology. Br J Pharmacol. 2021;178(21):4213-4215doi: 10.1111/bph.15632.
Maffia, P., Antoniades, C., Ahluwalia, A., & Cirino, G. (2021). Molecular imaging-The first visual themed issue published in the British Journal of Pharmacology. British journal of pharmacology, 178(21), 4213-4215. https://doi.org/10.1111/bph.15632
Maffia, Pasquale, et al. "Molecular imaging-The first visual themed issue published in the British Journal of Pharmacology." British journal of pharmacology vol. 178,21 (2021): 4213-4215. doi: https://doi.org/10.1111/bph.15632
Maffia P, Antoniades C, Ahluwalia A, Cirino G. Molecular imaging-The first visual themed issue published in the British Journal of Pharmacology. Br J Pharmacol. 2021 Nov;178(21):4213-4215. doi: 10.1111/bph.15632. PMID: 34664273.
Copy Download .nbib Format: NLM
Molecular imaging of cardiovascular inflammation.

British journal of pharmacology

MacRitchie N, Noonan J, Guzik TJ, Maffia P.
PMID: 34378206
Br J Pharmacol. 2021 Nov;178(21):4216-4245. doi: 10.1111/bph.15654. Epub 2021 Oct 14.

Cardiovascular diseases (CVDs), including atherosclerosis, are chronic inflammatory diseases characterised by a complex and evolving tissue micro-environment. Molecular heterogeneity of inflammatory responses translates into clinical outcomes. However, current medical imaging modalities are unable to reveal the cellular and molecular...

Cite
MacRitchie N, Noonan J, Guzik TJ, et al. Molecular imaging of cardiovascular inflammation. Br J Pharmacol. 2021;178(21):4216-4245doi: 10.1111/bph.15654.
MacRitchie, N., Noonan, J., Guzik, T. J., & Maffia, P. (2021). Molecular imaging of cardiovascular inflammation. British journal of pharmacology, 178(21), 4216-4245. https://doi.org/10.1111/bph.15654
MacRitchie, Neil, et al. "Molecular imaging of cardiovascular inflammation." British journal of pharmacology vol. 178,21 (2021): 4216-4245. doi: https://doi.org/10.1111/bph.15654
MacRitchie N, Noonan J, Guzik TJ, Maffia P. Molecular imaging of cardiovascular inflammation. Br J Pharmacol. 2021 Nov;178(21):4216-4245. doi: 10.1111/bph.15654. Epub 2021 Oct 14. PMID: 34378206.
Copy Download .nbib Format: NLM
Strategies for Reducing Non-Communicable Diseases in Africa.

Pharmacological research

Olowoyo P, Popoola F, Yaria J, Akinyemi R, Maffia P, Owolabi MO.
PMID: 34147659
Pharmacol Res. 2021 Aug;170:105736. doi: 10.1016/j.phrs.2021.105736. Epub 2021 Jun 17.

No abstract available.

Cite
Olowoyo P, Popoola F, Yaria J, et al. Strategies for Reducing Non-Communicable Diseases in Africa. Pharmacol Res. 2021;170:105736doi: 10.1016/j.phrs.2021.105736.
Olowoyo, P., Popoola, F., Yaria, J., Akinyemi, R., Maffia, P., & Owolabi, M. O. (2021). Strategies for Reducing Non-Communicable Diseases in Africa. Pharmacological research, 170105736. https://doi.org/10.1016/j.phrs.2021.105736
Olowoyo, Paul, et al. "Strategies for Reducing Non-Communicable Diseases in Africa." Pharmacological research vol. 170 (2021): 105736. doi: https://doi.org/10.1016/j.phrs.2021.105736
Olowoyo P, Popoola F, Yaria J, Akinyemi R, Maffia P, Owolabi MO. Strategies for Reducing Non-Communicable Diseases in Africa. Pharmacol Res. 2021 Aug;170:105736. doi: 10.1016/j.phrs.2021.105736. Epub 2021 Jun 17. PMID: 34147659.
Copy Download .nbib Format: NLM
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function.

Cell death and differentiation

Campbell KJ, Mason SM, Winder ML, Willemsen RBE, Cloix C, Lawson H, Rooney N, Dhayade S, Sims AH, Blyth K, Tait SWG.
PMID: 33785871
Cell Death Differ. 2021 Sep;28(9):2589-2600. doi: 10.1038/s41418-021-00773-4. Epub 2021 Mar 31.

High levels of the anti-apoptotic BCL-2 family member MCL-1 are frequently found in breast cancer and, appropriately, BH3-mimetic drugs that specifically target MCL-1's function in apoptosis are in development as anti-cancer therapy. MCL-1 also has reported non-canonical roles that...

Cite
Campbell KJ, Mason SM, Winder ML, et al. Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell Death Differ. 2021;28(9):2589-2600doi: 10.1038/s41418-021-00773-4.
Campbell, K. J., Mason, S. M., Winder, M. L., Willemsen, R. B. E., Cloix, C., Lawson, H., Rooney, N., Dhayade, S., Sims, A. H., Blyth, K., & Tait, S. W. G. (2021). Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell death and differentiation, 28(9), 2589-2600. https://doi.org/10.1038/s41418-021-00773-4
Campbell, Kirsteen J, et al. "Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function." Cell death and differentiation vol. 28,9 (2021): 2589-2600. doi: https://doi.org/10.1038/s41418-021-00773-4
Campbell KJ, Mason SM, Winder ML, Willemsen RBE, Cloix C, Lawson H, Rooney N, Dhayade S, Sims AH, Blyth K, Tait SWG. Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function. Cell Death Differ. 2021 Sep;28(9):2589-2600. doi: 10.1038/s41418-021-00773-4. Epub 2021 Mar 31. PMID: 33785871; PMCID: PMC8408186.
Copy Download .nbib Format: NLM
Degradation levels of continuous speech affect neural speech tracking and alpha power differently.

The European journal of neuroscience

Hauswald A, Keitel A, Chen YP, Rösch S, Weisz N.
PMID: 32687616
Eur J Neurosci. 2020 Jul 20; doi: 10.1111/ejn.14912. Epub 2020 Jul 20.

Making sense of a poor auditory signal can pose a challenge. Previous attempts to quantify speech intelligibility in neural terms have usually focused on one of two measures, namely low-frequency speech-brain synchronization or alpha power modulations. However, reports have...

Cite
Hauswald A, Keitel A, Chen YP, et al. Degradation levels of continuous speech affect neural speech tracking and alpha power differently. Eur J Neurosci. 2020;doi: 10.1111/ejn.14912.
Hauswald, A., Keitel, A., Chen, Y. P., Rösch, S., & Weisz, N. (2020). Degradation levels of continuous speech affect neural speech tracking and alpha power differently. The European journal of neuroscience, . https://doi.org/10.1111/ejn.14912
Hauswald, Anne, et al. "Degradation levels of continuous speech affect neural speech tracking and alpha power differently." The European journal of neuroscience vol. (2020). doi: https://doi.org/10.1111/ejn.14912
Hauswald A, Keitel A, Chen YP, Rösch S, Weisz N. Degradation levels of continuous speech affect neural speech tracking and alpha power differently. Eur J Neurosci. 2020 Jul 20; doi: 10.1111/ejn.14912. Epub 2020 Jul 20. PMID: 32687616.
Copy Download .nbib Format: NLM
Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.

Cardiovascular research

Murray EC, Nosalski R, MacRitchie N, Tomaszewski M, Maffia P, Harrison DG, Guzik TJ.
PMID: 34698811
Cardiovasc Res. 2021 Nov 22;117(13):2589-2609. doi: 10.1093/cvr/cvab330.

Both animal models and human observational and genetic studies have shown that immune and inflammatory mechanisms play a key role in hypertension and its complications. We review the effects of immunomodulatory interventions on blood pressure, target organ damage, and...

Cite
Murray EC, Nosalski R, MacRitchie N, et al. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective. Cardiovasc Res. 2021;117(13):2589-2609doi: 10.1093/cvr/cvab330.
Murray, E. C., Nosalski, R., MacRitchie, N., Tomaszewski, M., Maffia, P., Harrison, D. G., & Guzik, T. J. (2021). Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective. Cardiovascular research, 117(13), 2589-2609. https://doi.org/10.1093/cvr/cvab330
Murray, Eleanor C, et al. "Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective." Cardiovascular research vol. 117,13 (2021): 2589-2609. doi: https://doi.org/10.1093/cvr/cvab330
Murray EC, Nosalski R, MacRitchie N, Tomaszewski M, Maffia P, Harrison DG, Guzik TJ. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective. Cardiovasc Res. 2021 Nov 22;117(13):2589-2609. doi: 10.1093/cvr/cvab330. PMID: 34698811.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries